Information Provided By:
Fly News Breaks for May 8, 2019
May 8, 2019 | 18:21 EDT
Stifel analyst Adam Walsh upgraded Protagonist Therapeutics to Buy from Hold and raised his price target for the shares to $17 from $11.
News For PTGX From the Last 2 Days
There are no results for your query PTGX